Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus

Sponsor
Sun Yat-sen University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02721628
Collaborator
(none)
60
1
2
30
2

Study Details

Study Description

Brief Summary

Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus

Condition or Disease Intervention/Treatment Phase
  • Procedure: Epi-keratoplasty
  • Procedure: Collagen Cross-Linking
  • Device: Femtosecond laser
N/A

Detailed Description

Keratoconus is a bilateral corneal ecstatic disease which is not uncommon and always behaves progressively and results in visual impairment by inducing irregular astigmatism and corneal opacities.

Collagen Cross-Linking (CXL) is widely used in progressive keratoconus. The cornea is soaked with a riboflavin solution and then being exposed to ultraviolet-A radiation. The performance creates links between collagen fibrils in order to rigidify the corneal stroma and slow down the progression of keratoconus. However, the effectiveness is not satisfied and accompanied with risks of side effects and serious complications, such as pain for the first two post-operative days, temporary loss of visual acuity during the first three months, infection and stromal opacity due to corneal scarring.

Epi-keratoplasty is a reversible technique in which a corneal graft is transplanted on the recipients' eye with only removal of the epithelium of the receptor cornea. The procedure was assisted by femtosecond laser which allows precisely and neatly cutting. The graft strengths the whole host corneal rigidity and roughness and therefore renders the progression of keratoconus.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Femtosecond Laser Assisted Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
Study Start Date :
Sep 1, 2015
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Mar 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Epi-keratoplasty Group

Epi-keratoplasty Group: Reversible keratoplasty performed with only the removal of corneal epithelium of the host cornea. A donor graft is transplanted on the recipients' eye locating on the Bowman's layer.

Procedure: Epi-keratoplasty
Femtosecond laser assisted Epi-keratoplasty

Device: Femtosecond laser
Use in the epic-keratoplasty surgery

Active Comparator: Collagen Cross-Linking Group

Collagen Cross-Linking: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes

Procedure: Collagen Cross-Linking
Collagen Cross-Linking: Standard procedure, which is descriptor bellows: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes
Other Names:
  • CCL
  • Outcome Measures

    Primary Outcome Measures

    1. Changes of Spherical equivalent [01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years]

    Secondary Outcome Measures

    1. maximum keratometry (K-max) derived from computerized video keratography [01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years]

    2. minimum keratometry [01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years]

      also from computerized video keratography, the opposite description of K-max

    3. Visual acuity [01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years]

    Other Outcome Measures

    1. Spherical equivalent [01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • diagnosis of Keratoconus

    • Age ≥ 18 years old

    • Corneal thickness ≥ 400 µm

    • Progressive stage 1 to 3 keratoconus (Krumeich classification)

    Exclusion Criteria:
    • Corneal thickness < 400µm

    • Concomitant corneal disease

    • History of corneal surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ZhongShan Ophthalmic Center GuangZhou Guangdong China 510060

    Sponsors and Collaborators

    • Sun Yat-sen University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gao Xinbo, Attendant Doctor, Sun Yat-sen University
    ClinicalTrials.gov Identifier:
    NCT02721628
    Other Study ID Numbers:
    • zoc-ekccl2015
    First Posted:
    Mar 29, 2016
    Last Update Posted:
    Mar 29, 2016
    Last Verified:
    Mar 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Gao Xinbo, Attendant Doctor, Sun Yat-sen University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 29, 2016